Related Experiment Videos
Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis
1Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Histopathology
|April 12, 2002
Summary
Tumor size and American Joint Committee on Cancer (AJCC) stage are key prognostic factors for soft part leiomyosarcoma survival. These indicators reliably predict patient outcomes in this rare cancer.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Leiomyosarcoma of soft parts is a rare malignancy.
- Identifying prognostic factors is crucial for patient management and outcome prediction.
Purpose of the Study:
- To investigate prognostic factors influencing survival in soft part leiomyosarcoma.
- To identify reliable indicators for predicting patient outcomes.
Main Methods:
- Retrospective analysis of 267 soft part leiomyosarcoma cases.
- Univariate and multivariate analyses (Cox proportional hazards model) were employed.
- Evaluation of factors including tumor depth, size, mitotic rate, necrosis, and AJCC stage.
Main Results:
- Univariate analysis identified depth, tumor size (≥50 mm), high mitotic rate (>20/HPF), extensive necrosis (>50%), and high AJCC stage as significant negative prognostic factors.
- Multivariate analysis revealed tumor size and high AJCC stage as independent predictors of decreased survival.
Conclusions:
- Tumor size and AJCC stage are the most reliable prognostic parameters for soft part leiomyosarcoma.
- These factors are critical for accurate prognostication and treatment planning.